This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Express Scripts, Prime Therapeutics move to dismiss antitrust lawsuit from Michigan AG

( July 25, 2025, 22:31 GMT | Official Statement) -- MLex Summary: Prime Therapeutics, Express Scripts, and Evernorth Health, moved to dismiss US antitrust claims filed by the Michigan Attorney General Dana Nessel the compensation amounts they pay to non-pharmacy benefit manager-affiliated pharmacies in Michigan for prescription drugs, saying the claims are am effort to piggyback on an interim award from a private arbitration brought by an independent pharmacy against Prime that was decided under the wrong legal standard. “The state failed to conduct any investigation of the 2019 agreement that was the subject of that arbitration and that the state now challenges here. Nonetheless, the state proceeded to file a complaint in which it lacks standing and asserts untimely and otherwise deficient claims that warrant dismissal with prejudice,” they said. See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections